Does USTEKINUMAB Cause Decreased appetite? 1,805 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,805 reports of Decreased appetite have been filed in association with USTEKINUMAB (PYZCHIVA). This represents 2.1% of all adverse event reports for USTEKINUMAB.
1,805
Reports of Decreased appetite with USTEKINUMAB
2.1%
of all USTEKINUMAB reports
1,095
Deaths
1,187
Hospitalizations
How Dangerous Is Decreased appetite From USTEKINUMAB?
Of the 1,805 reports, 1,095 (60.7%) resulted in death, 1,187 (65.8%) required hospitalization, and 1,114 (61.7%) were considered life-threatening.
Is Decreased appetite Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for USTEKINUMAB. However, 1,805 reports have been filed with the FAERS database.
What Other Side Effects Does USTEKINUMAB Cause?
Drug ineffective (12,471)
Off label use (10,990)
Product dose omission issue (9,405)
Fatigue (5,457)
Product use issue (5,008)
Psoriasis (4,955)
Pain (4,872)
Rash (4,736)
Crohn's disease (4,662)
Arthralgia (4,608)
What Other Drugs Cause Decreased appetite?
ADALIMUMAB (6,135)
LENALIDOMIDE (5,103)
SEMAGLUTIDE (4,317)
METHOTREXATE (4,229)
CABOZANTINIB S-MALATE (4,076)
APREMILAST (3,442)
RITUXIMAB (3,438)
PALBOCICLIB (3,400)
PREDNISONE (3,390)
LENVATINIB (3,257)
Which USTEKINUMAB Alternatives Have Lower Decreased appetite Risk?
USTEKINUMAB vs USTEKINUMAB-STBA
USTEKINUMAB vs VADADUSTAT
USTEKINUMAB vs VALACYCLOVIR
USTEKINUMAB vs VALBENAZINE
USTEKINUMAB vs VALBENAZINE DITOSYLATE